These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 21531791

  • 21. Genetic variation in the EGFR gene and the risk of glioma in a Chinese Han population.
    Hou WG, Ai WB, Bai XG, Dong HL, Li Z, Zhang YQ, Xiong LZ.
    PLoS One; 2012; 7(5):e37531. PubMed ID: 22662167
    [Abstract] [Full Text] [Related]

  • 22. Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study.
    Wibom C, Späth F, Dahlin AM, Langseth H, Hovig E, Rajaraman P, Johannesen TB, Andersson U, Melin B.
    Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):810-6. PubMed ID: 25713050
    [Abstract] [Full Text] [Related]

  • 23. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
    Alpen K, Vajdic CM, MacInnis RJ, Milne RL, Koh ES, Hovey E, Harrup R, Bruinsma F, Nguyen TL, Li S, Joseph D, Benke G, Dugué PA, Southey MC, Giles GG, Rosenthal M, Drummond KJ, Nowak AK, Hopper JL, Kapuscinski M, Makalic E.
    Neuro Oncol; 2023 Jul 06; 25(7):1355-1365. PubMed ID: 36541697
    [Abstract] [Full Text] [Related]

  • 24. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & -191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA.
    Zahoor W, Pandith AA, Nisar S, Qasim I, Surana M, Ganie FA, Manzoor U, Arif SH, Rasool SUA, Lateef A, Shah P, Bhat RA.
    Exp Oncol; 2023 Oct 11; 45(2):203-210. PubMed ID: 37824771
    [Abstract] [Full Text] [Related]

  • 25. Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas.
    Park YW, Ahn SS, Park CJ, Han K, Kim EH, Kang SG, Chang JH, Kim SH, Lee SK.
    Eur Radiol; 2020 Dec 11; 30(12):6475-6484. PubMed ID: 32785770
    [Abstract] [Full Text] [Related]

  • 26. Age-dependent prognostic effects of genetic alterations in glioblastoma.
    Batchelor TT, Betensky RA, Esposito JM, Pham LD, Dorfman MV, Piscatelli N, Jhung S, Rhee D, Louis DN.
    Clin Cancer Res; 2004 Jan 01; 10(1 Pt 1):228-33. PubMed ID: 14734474
    [Abstract] [Full Text] [Related]

  • 27. Genetic causes of glioma: new leads in the labyrinth.
    Melin B.
    Curr Opin Oncol; 2011 Nov 01; 23(6):643-7. PubMed ID: 21825990
    [Abstract] [Full Text] [Related]

  • 28. Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification.
    Komori T.
    Brain Tumor Pathol; 2020 Jan 01; 37(1):1-4. PubMed ID: 32060660
    [No Abstract] [Full Text] [Related]

  • 29. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D.
    Clin Cancer Res; 1997 Jun 01; 3(6):977-81. PubMed ID: 9815774
    [Abstract] [Full Text] [Related]

  • 30. Molecular subtypes of glioma identified by genome-wide methylation profiling.
    Kloosterhof NK, de Rooi JJ, Kros M, Eilers PH, Sillevis Smitt PA, van den Bent MJ, French PJ.
    Genes Chromosomes Cancer; 2013 Jul 01; 52(7):665-74. PubMed ID: 23629961
    [Abstract] [Full Text] [Related]

  • 31. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
    Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, El Hallani S, Boisselier B, Mokhtari K, Hoang-Xuan K, Delattre JY.
    J Clin Oncol; 2009 Sep 01; 27(25):4150-4. PubMed ID: 19636000
    [Abstract] [Full Text] [Related]

  • 32. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
    Chen SC, Lo CM, Wang SH, Su EC.
    BMC Bioinformatics; 2019 Dec 24; 20(Suppl 19):659. PubMed ID: 31870275
    [Abstract] [Full Text] [Related]

  • 33. Hemizygous or homozygous deletion of the chromosomal region containing the p16INK4a gene is associated with amplification of the EGF receptor gene in glioblastomas.
    Hegi ME, zur Hausen A, Rüedi D, Malin G, Kleihues P.
    Int J Cancer; 1997 Sep 26; 73(1):57-63. PubMed ID: 9334810
    [Abstract] [Full Text] [Related]

  • 34. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.
    Costello JF, Plass C, Arap W, Chapman VM, Held WA, Berger MS, Su Huang HJ, Cavenee WK.
    Cancer Res; 1997 Apr 01; 57(7):1250-4. PubMed ID: 9102208
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
    Houdova Megova M, Drábek J, Dwight Z, Trojanec R, Koudeláková V, Vrbková J, Kalita O, Mlcochova S, Rabcanova M, Hajdúch M.
    Klin Onkol; 2017 Apr 01; 30(5):361-371. PubMed ID: 29031038
    [Abstract] [Full Text] [Related]

  • 37. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
    Stichel D, Ebrahimi A, Reuss D, Schrimpf D, Ono T, Shirahata M, Reifenberger G, Weller M, Hänggi D, Wick W, Herold-Mende C, Westphal M, Brandner S, Pfister SM, Capper D, Sahm F, von Deimling A.
    Acta Neuropathol; 2018 Nov 01; 136(5):793-803. PubMed ID: 30187121
    [Abstract] [Full Text] [Related]

  • 38. Fine mapping of a region of chromosome 11q23.3 reveals independent locus associated with risk of glioma.
    Chen H, Sun B, Zhao Y, Song X, Fan W, Zhou K, Zhou L, Mao Y, Lu D.
    PLoS One; 2012 Nov 01; 7(12):e52864. PubMed ID: 23300798
    [Abstract] [Full Text] [Related]

  • 39. Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis.
    Kinnersley B, Kamatani Y, Labussière M, Wang Y, Galan P, Mokhtari K, Delattre JY, Gousias K, Schramm J, Schoemaker MJ, Swerdlow A, Fleming SJ, Herms S, Heilmann S, Nöthen MM, Simon M, Sanson M, Lathrop M, Houlston RS.
    Eur J Hum Genet; 2016 May 01; 24(5):717-24. PubMed ID: 26264438
    [Abstract] [Full Text] [Related]

  • 40. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
    Gravendeel LA, Kloosterhof NK, Bralten LB, van Marion R, Dubbink HJ, Dinjens W, Bleeker FE, Hoogenraad CC, Michiels E, Kros JM, van den Bent M, Smitt PA, French PJ.
    Hum Mutat; 2010 Mar 01; 31(3):E1186-99. PubMed ID: 20077503
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.